Tracers / [11C]LY2795050
[11C]LY2795050
Also written as [11C]LY2795050; [C-11]LY2795050
- Radionuclide
- C-11 t½ 20.36 min
- Modality
- PET
- Production route
- —
- Stage
- —
- Syntheses indexed
- 2
What it is
- Compound class
- benzamide
- Target / mechanism
- KOR antagonist PMID 40857482
- Clinical application
- —
- Theranostic pair
- —
Regulatory status
- FDA
- —
- EMA (centralised)
- —
- Other approvals
- —
- Brand names
- —
Clinical use
- Typical injected activity
- —
- Uptake time
- —
Reported in the literature. Not a dosing recommendation.
Published syntheses
| Module | Cassette | Purification | Yield % | RCP % | Precursor / supplier | Source |
|---|---|---|---|---|---|---|
| TRACERlab FX (model not stated) GE HealthCare | — | HPLC | 8.4 ± 3.2% yes | 99.5 ± 0.7% | 17-I | 40857482 2025 Asian J Org Chem The methodology uses GE TRACERLab FX automated radiochemistry synthesis modules — RCY of 8.4 ± 3.2% (25 ± 9 mCi (942 ± 352 MBq) at end-of-syntheses, corresponding to 1.0 ± 0.41% non-decay-corrected RCY based upon ~92.5 GBq (~2.5 Ci) of starting [11C]CO, 62 min synthesis, n = 3) |
| — | — | — | near quantitative | — | — | 37513867 2023 Pharmaceuticals (Basel) |
Need this precursor?We can point you to suppliers for [11C]LY2795050, or handle the enquiry for you.
Get in touchQuality control Preliminary — inferred from compound class
- Ph. Eur. monograph
- —
- USP monograph
- —
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary)
Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived
Setting up quality control?We can help you scope the equipment needed to release [11C]LY2795050.
Get in touchNotes
Added from reverse module search (stage 6); 1 article(s) with C-11.